ACC Journal Club to Discuss Cardiovascular Risks of HER2-Positive Targeted Therapy
Audio narration · Coming soon
The American College of Cardiology's specialty journal JACC: CardioOncology is hosting a journal club aimed at fellows and trainees. The session will focus on exploring cardiovascular risks associated with HER2-positive targeted therapies, highlighting important developments in cardio-oncology.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews